General Information of This Drug (ID: DMVBPRO)

Drug Name
CP-673451   DMVBPRO
Synonyms CP-673,451
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL is unavailable 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

5 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
CP-673451 + Panobinostat DCKO7CV Panobinostat Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [2]
CP-673451 + AS602868 DCCO2HG AS602868 Hodgkin lymphoma (Cell Line: L-1236) [2]
CP-673451 + BGT226 DCY22GY BGT226 Hodgkin lymphoma (Cell Line: L-1236) [2]
PMID25656651-Compound-5 + CP-673451 DCE5NQG PMID25656651-Compound-5 Hodgkin lymphoma (Cell Line: L-1236) [3]
Vincristine + CP-673451 DCI4B2L Vincristine Hodgkin lymphoma (Cell Line: L-1236) [2]
------------------------------------------------------------------------------------

References

1 Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. Cancer Res. 2005 Feb 1;65(3):957-66.
2 CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125966
3 CheMBL Affinity Phenotypic Cellular Interaction Assay ID: CHEMBL1125976